Two other major governing bodies include URAC and ACHC accreditation, who govern pharmacies shipping GLP-1s and other medications
The major trials involving semaglutide have generally shown a low incidence of AFib among participants
You need more fiber than most people on these drugs are eating, but dumping a large fiber load (huge salad, full psyllium dose) into a slowed gut often worsens bloating and constipation
Most human trials primarily assess glycemic control, body weight, and lipid parameters rather than GLP-1 directly, so proposed incretin mechanisms often come from preclinical work
The results from a 48-week phase 2 trial in patients with obesity who are at risk of developing cardiovascular diseases, showed that patients had achieved a mean weight loss of 15.6% on a 2.4 mg dose of the drug, and notably, improvements in blood pressure as well as no cardiac event imbalances took place
Users lose weight during active treatment, attempt maintenance through lifestyle alone, then restart medication when regain reaches a predetermined threshold (often 10 to 15 pounds)